In a first set of experiments, we evaluated the effects of different d
oses (5.0, 10, 20 and 40 mg/kg p.o.) of carbamazepine on nociceptive t
hresholds to thermal and mechanical stimuli, and on paw inflammatory h
yperalgesia induced by the injection of brewer's yeast. Moreover, we s
tudied the effect of carbamazepine on paw inflammatory edema by plethy
smometry. Carbamazepine did not modify nociceptive latencies, but dose
dependently reduced the hyperalgesia and the edema induced by the bre
wer's yeast injection in the rat hindpaw. In a second set of experimen
ts, we studied the effects induced by the same doses of the drug on su
bcutaneous carrageenin-induced inflammation. Carbamazepine dose depend
ently reduced the inflammatory exudate, the prostaglandin E(2)-like ac
tivity in the exudate, and the substance P concentrations in the exuda
te. Our results demonstrate that carbamazepine is able to inhibit the
development of different types of inflammation in the rat.